# Viral genome editing methods and applications in the CRISPR era

**Authors:** Kihye Shin, Eui Tae Kim

PMC · DOI: 10.1128/jvi.02048-25 · Journal of Virology · 2026-02-18

## TL;DR

This review explains how CRISPR technology can be used to edit large DNA viruses like herpesviruses, offering a more efficient and flexible alternative to traditional methods.

## Contribution

The paper introduces a practical framework for optimizing CRISPR-based editing of large DNA viruses, including strategies for improving HDR efficiency and clone validation.

## Key findings

- CRISPR enables scarless knock-ins and conditional gene manipulation in essential viral loci.
- Optimized CRISPR designs work effectively without the need for complementing cell lines.
- CRISPR outperforms traditional BAC recombination for editing clinical isolates of large DNA viruses.

## Abstract

CRISPR-Cas systems have transformed viral genetics by enabling precise and efficient manipulation of large DNA virus genomes. This review provides a practical framework for applying CRISPR technology to herpesviruses and other large DNA viruses as an alternative and complement to traditional BAC recombination. Key considerations include nuclease choice; sgRNA design that minimizes cut-to-edit distance and prevents re-cutting; donor template configuration and homology arm length; and synchronized delivery of Cas complexes and donor DNA. Strategies to promote HDR efficiency, such as the use of small-molecule modulators, are also summarized. In addition, practical workflows for clone selection, genotypic validation, and phenotypic confirmation are summarized. Case studies in herpes simplex virus type 1 and human cytomegalovirus illustrate how optimized CRISPR designs achieve reproducible, scarless knock-ins and conditional gene manipulation at essential loci without complementing cell lines. Together, these approaches establish CRISPR as a flexible, scalable platform for functional genomics, antiviral target discovery, and translational virology, enabling direct editing of clinical isolates previously inaccessible with bacterial artificial chromosome-based methods.

## Full-text entities

- **Species:** Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Human betaherpesvirus 5 (no rank) [taxon 10359]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13011484/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13011484/full.md

## References

165 references — full list in the complete paper: https://tomesphere.com/paper/PMC13011484/full.md

---
Source: https://tomesphere.com/paper/PMC13011484